Furthermore, treatment with a small-molecule inhibitor of UCHL3 recapitulated the effects of UCHL3 lowering and attenuated pathological markers in Huntington's disease medium spiny neurons. This evidence concerns the gene UCHL3 and juvenile Huntington disease.